INC Research Holdings a Phase I to IV contract research organization (CRO), has launched the company’s Vaccine Catalyst Site network as part of its catalyst program introduced earlier this year to strengthen collaborations with clinical research sites worldwide, ultimately enhancing patient focus and optimizing study delivery to drive improved predictability and increased efficiency for customers.  INC selected 40 high-performing clinical research sites to participate in the initial launch of it...